SatRx is engaged in a wide range of pharmaceutical development of promising new compounds from high-performance screening, medicinal chemistry and early stages of pre-clinical development, to the full scope of clinical trials and marketing authorization of innovative medicines for the treatment of type 2 diabetes mellitus, metabolic syndrome, for solving transplantation problems.

Ajax Call Form